Journal profile · Dermatology

Journal of Dermatological Treatment

ISSN 0954-6634 · eISSN 1471-1753 · Informa Healthcare · SWEDEN · Bimonthly · Founded 1989

Journal of Dermatological Treatment: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 4.28; JCR Q1 (journal website); fully open access; APC about USD 4,000; median 48 days to acceptance (100 articles, last 24 months); community-reported acceptance: fairly easy; 193 articles in 2025; indexed in SCIE and Scopus.

Impact factor4.28Latest value listed by LetPub
CAS zoneZone 4 · Medicine2025 upgraded edition, major category · 2026 Xinrui edition Zone 3 · Medicine
Review time48 daysMedian, submission to acceptance · 100 articles, last 24 months · Crossref
APCUSD 4,000Fully open access
AcceptanceFairly easyCommunity average
Articles per year1932025 · OpenAlex count

Scope

Aims, scope and focus

Journal of Dermatological Treatment is published by Informa Healthcare and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Dermatology and Skin Diseases, Psoriasis: Treatment and Pathogenesis and Acne and Rosacea Treatments and Effects, together about 39% of its articles. Its main subfields are Dermatology. (generated from OpenAlex topic counts and CAS ranking data)

MEDLINE-indexed Journal of Dermatological Treatment covers topical, systemic, phototherapeutic, and other approaches to treating skin disease. The journal aims to give dermatologists practical value through cutting-edge information on new treatments in all areas of dermatology. Accepted content benefits from rapid review and full-color illustrations. The journal’s focus includes: Topical and systemic dermatological therapies, including novel biologicals Dermatological phototherapy Dermatological surgery and lasers Skin pharmacology Journal of Dermatological Treatment accepts research articles, review articles, case reports, brief reports, book reviews, discussion articles, and letters to the editor. The journal operates a single-anonymized peer review policy. *Please note that Journal of Dermatological Treatment converted to a full Open Access journal from Volume 34 (2023). Previous volumes will continue to provide access through a Pay to Read model. Please note, from 2023 the Print ISSN is not in active use as this journal is no longer published in print.

From the journal's Aims & Scope

Research area (LetPub): Dermatology

Editor-in-chief Peter Van de KerkhofPublisher website

Editorial board by country: none in mainland China; most named United States 2, United Kingdom 1, Germany 1, Netherlands 1 (5 members with a country) Editorial board ↗Publisher website ·

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Dermatology and Skin DiseasesMedicine16.6%
  2. Psoriasis: Treatment and PathogenesisImmunology and Microbiology16.1%
  3. Acne and Rosacea Treatments and EffectsMedicine6.3%
  4. Dermatologic Treatments and ResearchMedicine5.8%
  5. Spondyloarthritis Studies and TreatmentsMedicine5.5%
  6. Nail Diseases and TreatmentsMedicine5.1%
  7. Autoimmune Bullous Skin DiseasesMedicine4.2%
  8. Skin Protection and AgingMedicine3.8%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorDermatologyZone 3

Top journal: noReview journal: no

CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
LevelCategoryZone
MajorMedicineZone 3
MinorDermatologyZone 2

Top journal: noReview journal: not marked

CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorDermatologyZone 3

Top journal: noReview journal: no

JCR / CiteScore quartiles on the journal's website

Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website

Database indexing

SCIEScopusDOAJLetPub

International journal early-warning lists: not listed in any editionLetPub

Indexing the journal's website claims

MEDLINEEmbaseCurrent ContentsPublisher website

Other: Index Medicus, CABS, ChemicalAbstracts, CML DERMATOLOGY

As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

Impact factor
4.28LetPub ·
Impact factor (publisher) 2025
4.3Publisher website ·
5-year impact factor (publisher) 2025
3.3Publisher website ·
CiteScore 2026-06
7.4LetPub ·
CiteScore (publisher) 2025
7.4Publisher website ·
SJR 2026-06
1.1LetPub ·
SJR (publisher) 2025
1.1Publisher website ·
SNIP 2026-06
1.36LetPub ·
SNIP (publisher) 2025
1.36Publisher website ·
h-index
47LetPub ·
h-index
84OpenAlex ·
i10-index
2,140OpenAlex ·
2-year mean citedness
3.52OpenAlex ·
Self-citation rate
4.7%LetPub ·
Share of gold OA articles
99.77%LetPub ·

Volume

Articles per year
171LetPub ·
Downloads per year (publisher)
977,000Publisher website ·

Articles by year OpenAlex count · 4,263 in total · the current year is incomplete

YearArticlesOpen accessCitations
202615315377
2025193193519
20241651651,201
20231491491,603
2022134501,567
2021144572,319

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Review time from article dates manuscript dates registered with Crossref · to

48 daysMedian, submission to acceptance · P25–P75 32 days – 68 days

Acceptance to online
median 16 days (100 articles)
Submission to online
median 67 days
Sample
100 articles with submission and acceptance dates (377 in the window); the latest was accepted on

Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".

Other sources

Average review time (community reports)
6–12 weeksLetPub ·
Average acceptance (community reports)
Fairly easyLetPub ·
Submission to publication (journal-reported)
about 7 weeksDOAJ ·
Peer review
Single anonymous peer reviewDOAJ

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Fully open accessDOAJ

Every article is open access; authors usually pay an article processing charge (APC).

SourceAPCFee waiverLicenseObserved
DOAJAUD 5,570 / EUR 3,840 / GBP 3,200 / USD 4,000YesCC BY, CC BY-NC
Publisher websiteYes, amount not published——

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Submission

Article types and submission policies (journal website)

Article types accepted7
  1. book reviewsJournal of Dermatological Treatment accepts research articles, review articles, case reports, brief reports, book reviews, discussion articles, and letters to t…Length not stated
  2. brief reportsJournal of Dermatological Treatment accepts research articles, review articles, case reports, brief reports, book reviews, discussion articles, and letters to t…Length not stated
  3. case reportsJournal of Dermatological Treatment accepts research articles, review articles, case reports, brief reports, book reviews, discussion articles, and letters to t…Length not stated
  4. discussion articlesJournal of Dermatological Treatment accepts research articles, review articles, case reports, brief reports, book reviews, discussion articles, and letters to t…Length not stated
  5. letters to the editorJournal of Dermatological Treatment accepts research articles, review articles, case reports, brief reports, book reviews, discussion articles, and letters to t…Length not stated
  6. research articlesJournal of Dermatological Treatment accepts research articles, review articles, case reports, brief reports, book reviews, discussion articles, and letters to t…Length not stated
  7. review articlesJournal of Dermatological Treatment accepts research articles, review articles, case reports, brief reports, book reviews, discussion articles, and letters to t…Length not stated
Publisher website
Policy excerpts from the journal's websiteOpen access, Peer review
Open access Open access

Journal of Dermatological Treatment is an open access journal and only publishes open access articles. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research. Why choose open access? Increase the discoverability and readership of your article Make an impact and reach new readers, no…

Source ↗Publisher website ·
Peer review

Single-anonymized peer review policy Model summary

The journal operates a single-anonymized peer review policy.

Source ↗Publisher website ·

Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.

Profile

Publication details and official links

Publisher
Informa Healthcare
Country or region
SWEDEN
Language
English
Frequency
Bimonthly
Founded
1989
ISSN
0954-6634
Electronic ISSN
1471-1753
Latest issue on the website
Volume 37, Issue 1 (2026)
Official links

FAQ

Frequently asked questions about Journal of Dermatological Treatment

What CAS zone is Journal of Dermatological Treatment in?

In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Dermatological Treatment is in Zone 4 of Medicine, and in Zone 3 of the minor category Dermatology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.

What is the impact factor of Journal of Dermatological Treatment?

The latest impact factor listed by LetPub is 4.28; CiteScore 7.4, h-index 84.

How long does peer review take at Journal of Dermatological Treatment?

Based on the dates recorded on 100 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 48 days (interquartile range 32–68 days); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Fairly easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

What JCR quartile is Journal of Dermatological Treatment in?

The journal's website gives JCR Q1 (best quartile). JCR quartiles are Clarivate's to confirm and a different system from the CAS zones; in the CAS ranking the journal is in Zone 4 of Medicine.

Where are the editorial board members of Journal of Dermatological Treatment based?

Of the 5 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (2), United Kingdom (1) and Germany (1). Counted from the institutions listed on the board page; for reference only.

Which databases index Journal of Dermatological Treatment?

According to LetPub and DOAJ records, Journal of Dermatological Treatment is indexed in SCIE, Scopus and DOAJ. The journal's website also lists MEDLINE, Embase and Current Contents; that list has not been checked against each database.

Is Journal of Dermatological Treatment open access, and what is the APC?

Journal of Dermatological Treatment is a fully open-access journal. APC about USD 4,000.

Sources and updates

The facts on this page come from LetPub, DOAJ, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .